Thanks for the info. It is important information even if it is past history and delayed. I want to spend time with these and focus on most important aspects.
I do think item 1A is worth skimming over just in case you find a serious challenge to a business. I was reading AbbVie's 10k a few weeks ago and one of their major risk factors is that they are facing competition for some of their leading medications by biosimilar drugs/generics. Besides for that risk factor, their business looked strong- but I could see the value of the company significantly decreasing because of this risk factor.
For majority of the companies, the 1A is not providing a lot of useful information. For a handful of companies that are quite specific, it is definitely important to look at the competition and what can put them out of business. Biotech is definitely a great example.
Also, I was wondering if you think COVID risk factors are still significant? Nearly all the 10ks I've read recently have listed it as a risk factor, but since this year the situation has changed quite a bit for the better
@@alexkesin All potential future pandemics are risk factors, same as all future wars. If we assume the end of the world is near, well, no point in valuing any company :) What might make more sense is to be diversified. So, looking back at the pandemic, what are the companies that benefited from it and the ones that didn't? If you want to protect yourself from these risks, that's the only way. Same goes for diversification by buying companies in different industries & geographical regions.
The way you described risk factors is so good
Glad you enjoyed it :)
Thanks for the info. It is important information even if it is past history and delayed. I want to spend time with these and focus on most important aspects.
Great video. Watched the whole way through and great recap! :)
I am glad you enjoyed it!
Great video!
💯💯💯
Thank you!
I do think item 1A is worth skimming over just in case you find a serious challenge to a business. I was reading AbbVie's 10k a few weeks ago and one of their major risk factors is that they are facing competition for some of their leading medications by biosimilar drugs/generics. Besides for that risk factor, their business looked strong- but I could see the value of the company significantly decreasing because of this risk factor.
For majority of the companies, the 1A is not providing a lot of useful information. For a handful of companies that are quite specific, it is definitely important to look at the competition and what can put them out of business. Biotech is definitely a great example.
Also, I was wondering if you think COVID risk factors are still significant? Nearly all the 10ks I've read recently have listed it as a risk factor, but since this year the situation has changed quite a bit for the better
@@alexkesin All potential future pandemics are risk factors, same as all future wars. If we assume the end of the world is near, well, no point in valuing any company :) What might make more sense is to be diversified. So, looking back at the pandemic, what are the companies that benefited from it and the ones that didn't? If you want to protect yourself from these risks, that's the only way. Same goes for diversification by buying companies in different industries & geographical regions.
Great video
Thank you!
Nice video, thanks!
I am glad you enjoyed it!